ArticleACS medicinal chemistry letters2021

Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1.

Emily C Cherney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.